Virtus Lifesci Biotech Etf Performance
| BBC Etf | USD 27.46 0.24 0.87% |
The entity has a beta of 1.61, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Virtus LifeSci will likely underperform.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental drivers, Virtus LifeSci is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| In Threey Sharp Ratio | -0.35 |
Virtus |
Virtus LifeSci Relative Risk vs. Return Landscape
If you would invest 2,703 in Virtus LifeSci Biotech on September 1, 2024 and sell it today you would earn a total of 43.00 from holding Virtus LifeSci Biotech or generate 1.59% return on investment over 90 days. Virtus LifeSci Biotech is generating 0.0441% of daily returns assuming volatility of 1.9615% on return distribution over 90 days investment horizon. In other words, 17% of etfs are less volatile than Virtus, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Virtus LifeSci Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Virtus LifeSci's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Virtus LifeSci Biotech, and traders can use it to determine the average amount a Virtus LifeSci's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0225
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BBC |
Estimated Market Risk
| 1.96 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Virtus LifeSci is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.
Virtus LifeSci Fundamentals Growth
Virtus Etf prices reflect investors' perceptions of the future prospects and financial health of Virtus LifeSci, and Virtus LifeSci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virtus Etf performance.
| Price To Earning | 39.87 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 1.99 X | |||
| Total Asset | 18.12 M | |||
About Virtus LifeSci Performance
By analyzing Virtus LifeSci's fundamental ratios, stakeholders can gain valuable insights into Virtus LifeSci's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Virtus LifeSci has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Virtus LifeSci has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.| Latest headline from news.google.com: CSHL and Range ETFs launch new partnership - Cold Spring Harbor Laboratory | |
| Virtus LifeSci Biotech generated five year return of -3.0% | |
| This fund holds 98.9% of its assets under management (AUM) in equities |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.